SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

TCM obtains loan license from Central Drugs Standard Control Organisation

21 Sep 2020 Evaluate

TCM has now obtained the loan license to manufacture for sale or for distribution of Class C or Class D medical device from the Central Drugs Standard Control Organisation (COSCO) for manufacturing SARS-COV-2 RT PCR Kits with the use of Technology licensed by IIT-Delhi on a non-exclusive basis. FITI will provide the technical support for implementation of the License.

TCM is engaged in the manufacture of Potassium Chlorate - a vital raw material for the match Industry.

TCM Share Price

50.89 0.00 (0.00%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3703.10
Tata Chemicals 709.05
SRF 2493.65
Pidilite Inds. 1393.25
Deepak Nitrite 1538.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×